January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Stingray Therapeutics
Stingray is a clinical stage biotech company that has developed potent and selective small molecule inhibitors of ENPP1, Ectonucleotide Pyrophosphatase / Phosphodiesterase1.